Mailing Address

Richard Lehner, PhD
315 Heritage Medical
Research Centre
University of Alberta
Edmonton, Alberta
T6G 2S2 Canada
Richard Lehner, PhD
Richard Lehner, PhD | Print |  E-mail
Professor of Pediatrics and Cell Biology & Director, MCBL Group

Research Interests: Regulation of triacylglycerol and cholesterol metabolism

Triacylglycerol (TG) is the most concentrated form of energy storage available to mammals. Excessive TG storage is manifested as obesity which is a major health problem in the Western world. Obesity currently affects more than 20% of adults in North America and it is a risk factor for hypertension, diabetes and cardiovascular disease. Elevated plasma LDL cholesterol levels are directly correlated with the risk of atherosclerosis. Therefore, there is a substantial pharmacological interest in the enzymes that control TG and cholesterol metabolism in tissues.

I. Triacylglycerol Hydrolase (TGH):

Hypothesis: TGH is involved in the mobilization of intracellular TG stores in the liver and adipose tissue and inhibition of this enzyme's activity will result in decreased plasma lipid levels.

Project involves: cell biology (localization and targeting, lipid droplet formation and turnover), biochemistry (active site, lipid binding, structure), molecular biology (generation and analysis of TGH transgenic and knock out mice), physiology (hormonal regulation).

II. Carboxylesterase Es-x:

Hypothesis: Es-x participates in intestinal and hepatic lipid metabolism.

Project involves: studies on the role of the enzyme in lipid metabolism in hepatocytes and in Es-x knock out mice.

III. Arylacetamide deacetylase (AADA):

Hypothesis: AADA participates in hepatic TG metabolism.

Project involves: cell biology of retention of AADA in the endoplasmic reticulum; studies on the role of the enzyme in lipid metabolism in hepatocytes transfected with AADA cDNA, and in AADA transgenic and knock out mice.

IV. Hepatic Cholesterol Efflux and Secretion:

Hypothesis: Depletion of hepatic cholesterol stores by efflux will result in decreased amount of cholesterol available for VLDL assembly.

Project involves: studying of cholesterol efflux and lipoprotein assembly in hepatocytes of various genetically modified mice and in the presence of inhibitors of lipid metabolism.

 

Last Updated on Thursday, 07 January 2010 19:04